2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Anticancer Drugs
Anticancer drugs play a crucial role in the fight against cancer, targeting and eliminating malignant cells while sparing healthy tissue. Recent advancements in cancer research have led to the development of more precise and effective treatments, such as targeted therapies and immunotherapies. Targeted therapies focus on specific molecular alterations in cancer cells, offering a personalized approach to treatment. Immunotherapies harness the power of the body's immune system to recognize and attack cancer cells, providing long-lasting responses and reduced side effects compared to traditional chemotherapy. Additionally, combination therapies, which use multiple anticancer agents, have shown promise in overcoming drug resistance and improving patient outcomes. Continuous research and clinical trials are essential to discover novel drugs and optimize existing treatments, offering hope for more effective cancer management and improved survival rates.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China